The American Economic Liberties Project wrote to HHS Secretary Xavier Becerra to outline four ways HHS could lower drug costs: 1) use compulsory patent licensing provisions in federal law to bring new insulin manufacturers to market and increase competition; 2) restore fair markets for independent pharmacies and purchasers by eliminating predatory fees, unfair patient steering, and anti-kickback exemptions for group purchasers; 3) enforce laws against pharmaceutical companies that have repeatedly engaged in illegal conduct to harm competition; and 4) use participation in Medicare Part D and in Medicaid to encourage competition.
